Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

Deals with Hims & Hers, LifeMD and Ro follow dismissal of a lawsuit that challenged the FDA's determination Wegovy is no ...

Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...

Using Wegovy consistently helps ensure the drug works effectively. It’s recommended that you give yourself Wegovy once per week, on the same day each week. But if you’re traveling and can’t ...

Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...

Novo Nordisk has pulled ahead in the race to bring the first oral GLP-1 for obesity to market. The company announced Friday ...

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...

CVS’ pharmacy benefit manager Caremark also reached an agreement with Danish drugmaker Novo Nordisk to give its weight loss drug Wegovy preferred access on Caremark’s standard formulary ...

Lilly’s rival drug, Zepbound, proved in testing that it could help people with obesity lose more weight than Wegovy, which some analysts think should give it an edge in marketing. Moreover ...

Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...